StonvexLoading…
StonvexStonvexStonvexCore line items from VIVS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $144.00K | $109.00K | $370.00K | $1.50M |
Operating Income | $-12.62M | $-15.09M | $-17.73M | $-11.48M |
Net Income | $-2.49M | $-14.67M | $-17.26M | $-11.45M |
EPS (Diluted) | $-1.70 | $-19.25 | $-1.98 | $-1.32 |
Total Assets | $14.65M | $6.35M | $20.31M | $33.30M |
Total Liabilities | $4.16M | $2.75M | $4.98M | $3.09M |
Cash & Equivalents | $11.31M | $2.90M | $15.30M | $28.68M |
Free Cash Flow OCF − CapEx | $-9.47M | $-14.70M | $-12.80M | $-8.86M |
Shares Outstanding | 1.90M | 839.81K | 8.72M | 8.71M |